… In a study performed at our center, a small group of patients exhibited significant … systemic
disease after an average of ii months of photopheresis therapy.^ We present a follow-up study …

… Nineteen patients with progressive systemic sclerosis of less … , is an effective treatment in
systemic sclerosis. The difference in … The magnitude of the effect, in this study defined as the …

… To our best knowledge, the present study is the first to report 20 years of follow-up for SSc
patients that received ECP. In general, reports on 20-year survival rates in SSc patients are …

… In the present study, 11 patients with progressive SSC of … In previous studies, EXP was
applied either for 1 year or less … 25), as in a follow-up of a study by Di Spaltro and colleagues …

… The aim of this study was to evaluate the clinical and … form is characterized by rapidly
progressive fibrosis of the skin … Debrecen, where they received regular follow-up and treatment. …

… In the study, we investigated the influence of extracorporeal … processes result in progressive
deterioration and atrophy of … As part of the routine clinical follow-up, we examined the skin …

… One study describes a three-year follow up of 12 patients with oral … drugs similarly to systemic
sclerosis therapy, but also by ECP and … chronic progressive multiple sclerosis: a pilot study …

… Systemic sclerosis (SSc) is a systemic autoimmune disease … SSc is dominated by rapidly
progressive fibrosis of skin and … Extracorporeal photochemotherapy (ECP), also known as …

… published clinical studies for ECP in systemic sclerosis, albeit … However, little to no follow-up
data is available to assess for … with scleroderma and should be applied to early progressive …

… in SSD dates back yet 1990 when photochemotherapy with 8-… evaluating extracorporeal
photopheresis were skipped. … 33 months of follow-up, but then she developed scleroderma renal …